Martin & Co. Inc. TN Purchases Shares of 65,628 Merit Medical Systems, Inc. $MMSI

Martin & Co. Inc. TN purchased a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 65,628 shares of the medical instruments supplier’s stock, valued at approximately $4,551,000. Merit Medical Systems makes up 0.7% of Martin & Co. Inc. TN’s holdings, making the stock its 29th largest holding. Martin & Co. Inc. TN owned approximately 0.11% of Merit Medical Systems as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of MMSI. William Blair Investment Management LLC bought a new stake in shares of Merit Medical Systems in the 2nd quarter valued at $78,894,000. Wellington Management Group LLP grew its holdings in Merit Medical Systems by 377.7% in the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after purchasing an additional 980,823 shares during the period. Norges Bank acquired a new stake in Merit Medical Systems in the fourth quarter worth $75,957,000. Bank of New York Mellon Corp bought a new stake in Merit Medical Systems in the second quarter valued at $28,470,000. Finally, Iron Triangle Partners LP bought a new stake in Merit Medical Systems in the fourth quarter valued at $33,992,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Up 0.6%

Shares of NASDAQ MMSI opened at $90.78 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The company has a 50-day moving average price of $77.41 and a 200-day moving average price of $72.57. The stock has a market capitalization of $5.42 billion, a P/E ratio of 37.51, a P/E/G ratio of 2.28 and a beta of 0.49. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The company had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the prior year, the business posted $1.01 EPS. The firm’s revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, equities research analysts forecast that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MMSI. Wells Fargo & Company increased their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Robert W. Baird set a $98.00 target price on Merit Medical Systems in a research report on Friday, July 31st. Weiss Ratings raised Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Barrington Research set a $114.00 price target on Merit Medical Systems in a report on Friday, July 31st. Finally, Needham & Company LLC raised their price objective on Merit Medical Systems from $90.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems has an average rating of “Moderate Buy” and an average target price of $100.00.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.